EPISODE · Feb 24, 2026 · 7 MIN
OnabotulinumtoxinA and Migraine: Clinical Insights and Recent Evidence
from Medical News Podcast · host PeerDirect Publishing
Drs. Ailani and Dougherty discuss onabotulinumtoxinA, a cornerstone treatment for chronic migraine, which reduces headache days and disability when given regularly with the PREEMPT protocol. They emphasize its unique benefits and how it pairs with CGRP therapies, oral preventives, and lifestyle changes for individualized care.
Embed this episode
NOW PLAYING
OnabotulinumtoxinA and Migraine: Clinical Insights and Recent Evidence
0:00
7:30
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Medical News Podcast?
This episode is 7 minutes long.
When was this Medical News Podcast episode published?
This episode was published on February 24, 2026.
Can I download this Medical News Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!